Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (5064)

SortShow
Name Institution Why
Nathanael Gray, Ph.D.Dana-Farber Cancer Institute Why?
Alice Tsang Shaw, Ph.D., M.D.Massachusetts General Hospital Why?
Keith Thomas Flaherty, M.D.Massachusetts General Hospital Why?
Lecia Vandam Sequist, M.D.Massachusetts General Hospital Why?
Daniel Botelho Costa, M.D.Beth Israel Deaconess Medical Center Why?
Toni K. Choueiri, M.D.Dana-Farber Cancer Institute Why?
James Douglas Griffin, M.D.Dana-Farber Cancer Institute Why?
Ellen L. Weisberg, Ph.D.Dana-Farber Cancer Institute Why?
Geoffrey Ira Shapiro, M.D., Ph.D.Dana-Farber Cancer Institute Why?
George Daniel Demetri, M.D.Dana-Farber Cancer Institute Why?
Jennifer Ruth Brown, Ph.D., M.D.Dana-Farber Cancer Institute Why?
Richard M. Stone, M.D.Dana-Farber Cancer Institute Why?
Jorge Castillo, M.D.Dana-Farber Cancer Institute Why?
Justin Franklin Gainor, M.D.Massachusetts General Hospital Why?
Bruce Evan Johnson, M.D.Dana-Farber Cancer Institute Why?
Per Page    Page  of 338last Nextnext
Prev
Search Criteria
  • Protein Kinase Inhibitors
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.